Special Issue
Innovations in Biomedical Research and Clinical Medicine
Guest Editor: Editorial Board — Journal of Biomedical Research & Environmental Sciences
Submission
Covid-19 Research
Safety Profile of COVID-19 Vaccines: Retrospective Analysis of Short, Medium, and Long-Term Side Effects: The Military Hospital Experience – Read more Evaluating the Efficacy of Different SARS-Cov-2 Drug Targets Using the Topo-Geometrical Superposition Algorithm, Molecular Docking and Chemical Reactivity Frameworks – Read more Preventing COVID-19 Infection by Complementary Medicine and Oral Health – Read more Analysis of Body Temperature in Patients with Trauma Visiting a Local Emergency Medical Center during the SARS-CoV-2 Outbreak – Read more N95 Respirator Fit Testing Experience during the Pandemic at a Singapore Tertiary Health Institution: Streamlining Workflow and Improving Respirator Fit Rate – Read more COVID-19 is an Amplifier of Social Inequalities Structural Violence against Students with Special Learning Needs and Low Socio-Economic Status – Read more Interaction between Chronic Influenza and COVID-19: Novel Aspects of Immune System Combat – Read more Daily Life, Fear of COVID-19 and Social Support in the Older Adults in Home Isolation: A Cross-Sectional Study – Read more The Impact of COVID-19 Pandemic on Cardiovascular Diseases in Brazil – Read more Diversity of Non-Influenza Respiratory Viruses Associated with Influenza-Like Illness during 2009 pre and pandemic periods in Sao Paulo, Brazil, a Historical Overview – Read more Cardiovascular Complications of SARS-CoV-2 (COVID-19) in Adults – Read more Impact of COVID-19 Pandemic on the Development of Childrens Executive Functions Implications for School-Based Interventions – Read more The Impact of the COVID-19 Pandemic on Youth Education – Read more Association between Dietary Habits, Lifestyle and Migraine Attacks During Social Isolation in the COVID-19 Pandemic: A Systematic Review of Observational Studies – Read more The Brazilian Increase in Cases of Lung Cancer and COVID-19, Can They be related? – Read more The Possible Therapeutic Application of CO on COVID-19 – Read more Planetary View of COVID Impact vs. IQ & PISA Rank as National Level of Intelligence – Read more Electrophysiological Study in a Patient with Visual Deficit after Severe Coronavirus 2 Pneumonia – Read more A Presentation of Analyses of COVID-19 Vaccine Samples, Blood Samples, Urine Samples, Foot Bath Samples, Sitz Bath Samples, and Skin-Extract Samples – Read more Is Anosmia-Ageusia in COVID-19 Patients Associated with Neuro-Philic Virus Mutant and Mild Respiratory Involvement? – Read more
Home/ All Articles/ The Recombinant NS3 Protein a Potential Antigen for Dengue Vaccine Development

Abstract & Article Details

Brief Report • Vol.5, Issue 4 • ISSN: 2766-2276 • Open Access • CC BY 4.0

Open Access Brief Report Vol.5, Issue 4 April 5, 2024

The Recombinant NS3 Protein a Potential Antigen for Dengue Vaccine Development

DOI: 10.37871/jbres1894
Authors
Rosa Ramirez Bartutis*
Full Text PDF

Abstract

The NS3 protein is a multifunctional non-structural protein involved in dengue virus polyprotein processing. This protein is also target in the immune response against dengue virus infection. The predominance of cytotoxic T-cell lymphocytes epitopes in the NS3 structure suggests the participation of this protein in limiting virus replication and in the protection against dengue disease. A brief presentation on aspects related to antigenic characteristics and immunogenicity of the recombinant NS3 protein is reported in this work. A reduced number of studies have assessed the NS3 protein in a dengue vaccine formulation. Researches carried out in mice shown that DNA vaccines based on NS3 protein induced a protective response evaluated by their ability to produce IFNγ. Moreover, the incorporation of recombinant subunit NS3 in a purified inactivated vaccine significantly increased the immune response induced by this inactivated vaccine. Likewise, recent studies demonstrated that the combination of the recombinant modified-NS1 and NS3 proteins from dengue 2 virus induced higher immune responses and protection in mice. The immunological studies discussed herein support the possible inclusion of the NS3 protein in a dengue vaccine formulation.

Research Topics

How to Cite

Rosa Ramirez Bartutis* (2024). The Recombinant NS3 Protein a Potential Antigen for Dengue Vaccine Development. Journal of Biomedical Research & Environmental Sciences, 5(4). https://doi.org/10.37871/jbres1894

Article Information

JournalJournal of Biomedical Research & Environmental Sciences (JBRES)
ISSN2766-2276
DOI DOI 10.37871/jbres1894
Volume / IssueVol. 5, Issue 4
PublishedApril 5, 2024
Article TypeBrief Report
Pages290-295
LicenseCC BY 4.0 — Open Access
PublisherSciRes Literature LLC, Sheridan, WY, USA
LanguageEnglish
Creative Commons BY 4.0

Published under CC BY 4.0 — free to share, copy, adapt, and redistribute with attribution.

Certificate of Publication

Certificate of Publication — The Recombinant NS3 Protein a Potential Antigen for Dengue Vaccine Development

Certificate verifies that this article was peer-reviewed and published in the Journal of Biomedical Research & Environmental Sciences.

Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable